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Abstract
Background: DNA triplexes can naturally occur, co-localize and interact with many other
regulatory DNA elements (e.g. G-quadruplex (G4) DNA motifs), specific DNA-binding proteins
(e.g. transcription factors (TFs)), and micro-RNA (miRNA) precursors. Specific genome
localizations of triplex target DNA sites (TTSs) may cause abnormalities in a double-helix DNA
structure and can be directly involved in some human diseases. However, genome localization of
specific TTSs, their interconnection with regulatory DNA elements and physiological roles in a cell
are poor defined. Therefore, it is important to identify comprehensive and reliable catalogue of
specific potential TTSs (pTTSs) and their co-localization patterns with other regulatory DNA
elements in the human genome.
Results: "TTS mapping” database is a web-based search engine developed here, which is aimed to
find and annotate pTTSs within a region of interest of the human genome. The engine provides
descriptive statistics of pTTSs in a given region and its sequence context. Different annotation
tracks of TTS-overlapping gene region(s), G4 motifs, CpG Island, miRNA precursors, miRNA
targets, transcription factor binding sites (TFBSs), Single Nucleotide Polymorphisms (SNPs), small
nucleolar RNAs (snoRNA), and repeat elements are also mapped based onto a sequence location
provided by UCSC genome browser, G4 database http://www.quadruplex.org and several other
datasets. The results pages provide links to UCSC genome browser annotation tracks and relative
DBs. BLASTN program was included to check the uniqueness of a given pTTS in the human
genome. Recombination- and mutation-prone genes (e.g. EVI-1, MYC) were found to be significantly
enriched by TTSs and multiple co-occurring with our regulatory DNA elements. TTS mapping
reveals that a high-complementary and evolutionarily conserved polypurine and polypyrimidine
DNA sequence pair linked by a non-conserved short DNA sequence can form miR-483 transcribed
from intron 2 of IGF2 gene and bound double-strand nucleic acid TTSs forming natural triplex
structures.
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Open AccessConclusion: TTS mapping provides comprehensive visual and analytical tools to help users to find
pTTSs, G-quadruplets and other regulatory DNA elements in various genome regions. TTS
Mapping not only provides sequence visualization and statistical information, but also integrates
knowledge about co-localization TTS with various DNA elements and facilitates that data analysis.
In particular, TTS Mapping reveals complex structural-functional regulatory module of gene IGF2
including TF MZF1 binding site and ncRNA precursor mir-483 formed by the high-complementary
and evolutionarily conserved polypurine- and polypyrimidine-rich DNA pair. Such ncRNAs capable
of forming helical triplex structures with a polypurine strand of a nucleic acid duplexes (DNA or
RNA) via Hoogsteen or reverse Hoogsteen hydrogen bonds. Our web tool could be used to
discover biologically meaningful genome modules and to optimize experimental design of anti-gene
treatment.
Introduction
It is known that nucleic acids are flexible molecules that
can exist in one of numerous spatial and temporal
conformations. In particular, at normal physiological
conditions DNA and RNA are both capable of forming
helical structures containing some specific genome regions
three strands. The existence of triple-stranded nucleic acids,
usually named ‘triplexes’, was first demonstrated by
Felsenfeld and collaborators [1]. This conformation is
obtained by the insertion of a third strand inside the major
groove of a double-stranded (duplex) nucleic acid
(Figure 1). Triplexes can contain DNA only, RNA only or
the mixture of both, and they are stabilized by the
Hoogsteen hydrogen bonds. The most stable triplex
conformations are those involving DNA alone or an RNA
sequence entering the major groove of a DNA duplex.
Among triplexes, the most stable triads are those involving
a protonated cytosine (C+) forming C+*GC triad and T*AT
nucleotides (the asterisks mark the nucleotides on the third
strand). Notably, these sequences are overrepresented in all
eukaryotic genomes, as well as in eukaryotic viruses [2,3]. It
is also possible to have a triplex formation without
homopurine stretches, and these triplexes seem to be as
stable as all others, at least, under certain conditions in
vitro. Figure 1 shows schematically three possible triplex
motifs bound to TTS in different orientation. This schema
shows how the third strand of a nucleic acid can form a
triplex structure with a polypurine strand of a nucleic acid
duplex (or TTS) via Hoogsteen or reverse Hoogsteen
hydrogen bond.
Although triplexes have been well characterized in vitro
and their role is studying in clinical trials, their biological
significance in living organisms is still under discussion
[2,4]. It was demonstrated that once formed, these
structures can frequently cause down-regulation and some-
times up-regulation of gene expression revealing their
potential role in gene expression control and suggesting
their application in gene therapy [2,3]. These structures are
also able to impair DNA polymerization, and can influence
DNA recombination and repair [5]. Triplexes might also
have a role in chromatin organization of both interphase
nuclei and mitotic chromosomes [6]. Recently, it was
demonstrated that a triple stranded pseudo-knot is a
conserved essential element of telomerase RNA, for
instance in humans [7]. A number of proteins able to
bind triplexes have been identified [8]. TTS sequences are
common in mammalian genes. Most annotated protein-
coding genes in human and other mammalian genomes
contain, at least, one unique and high-affinity TTS in their
(putative) promoters and/or transcribed regions [3,9].
RNAs are integral components of chromosomes and
contribute to their structural organization and the
functions of various chromosome regions [10]. Naturally
occurring small interference RNAS (siRNAs) and closely
related class of non-coding micro-RNAs (miRNAs) could
play an essential regulatory role in eukaryotic gene
expression and cell function [10,11]. It is now becoming
apparent that chromatin architecture and epigenetic
memory can be regulated by ncRNA-directed processes,
although their exact mechanisms are yet to be under-
stood [10]. It was shown that specific ncRNAs are able to
form natural triplexes (purine-purine-pyrimidine triplex
structure called H-DNA-DNA-RNA form) with major
promoter regions of DHFR gene and switch alternative
transcriptional isoforms of genes [11]. miRNA-based
anti-gene therapy is now considered as a very promising
tool for modulation of gene expression and cell
phenotype. However, chromosome co-localization and
functional relationships between miRNAs and other
types of ncRNAs and TTSs have not been systematically
studied.
Certain guanine-rich sequences can often co-localized
with TTSs. Certain guanine-rich sequences can fold
spontaneously into four stranded DNA structure
known as G4 DNA motifs [12]. The structure of G4,
which comprises stacked G-tetrads, has a square planar
arrangement of four guanine bases stabilized by
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physiological conditions. Recent studies have demon-
strated that the G4 DNA structures formed in regulatory
regions (e.g. promoters) could be overlapped with pTTSs
and regulate gene expression [12,13]. A well-known
example of such regulation is the repressive effect of G4
DNA on the transcription of human MYC gene [14]. The
transcriptional activity of MYC gene is reduced consider-
ably when a parallel G4 DNA formed in the nuclease
hypersensitive element III1 upstream of the P1 promoter
is stabilized by the G4 ligand TMPyP4 [14]. However,
relatively little is known about the detailed molecular
mechanism by which G4 DNA influences genome
properties. Consecutive guanine structures and guanine
content may attribute the high binding affinity of TFOs
to their targets [15,16]. Therefore, TTSs including G4
might be perspective genome elements for development
novel triplex strategies.
It has been demonstrated in vitro and in vivo that TFOs
targeting promoter regions and genic regions of onco-
genes and other disease-related genes can diminish the
expression of genes, prohibit cell proliferation, and
induce apoptosis in the cells [16]. These results also
Figure 1
Schema of three triplex motifs bind to TTS by different orientation. This schema shows three triplex motifs of third
sequence strand which can form triplex structure with polypurine of duplex (or TTS) via Hoogsteen or reverse Hoogsteen
hydrogen bond. In CT motif, the third strand is parallel with TTS by forming Hoogsteen hydrogen bond. In the GT motif, the
third strand can be either anti-parallel to the third strand by forming reverse Hoogsteen or parallel by forming Hoogsteen
hydrogen bond. In GA motif, the third strand is anti-parallel with TTS by forming.
BMC Genomics 2009, 10(Suppl 3):S9 http://www.biomedcentral.com/1471-2164/10/S3/S9
Page 3 of 18
(page number not for citation purposes)suggest that the effects of TFOs on endogenious gene
expression may depend on the specific chromatin
structure of specifically addressed gene. In particular,
status of nucleosome occupancy might be considered as
the factor of efficiency of triplex formation [16-18].
Two TTS WEB resources and search tools of pTTSs in the
human genome have been proposed till now. For the
first one, TRACTs [19] software, the input is the gene
sequence, additionally, the starting and the ending
positions of each exon and each intron. The input for
this tool can be generated from parsing annotated
sequences. The specificity of the input DNA sequence
and the annotation of the sequence without explicit
intron and exon description of the annotated gene is not
reported by TRACTs. The second, TFO target sites tool
reported by Gaddis in 2006 [20], has also provide
information about TTS sequences for annotated gene
(chosen by several annotated Ids). The pTTSs in gene-
flanking regions can also be optimized. The both tools
use different criteria of identification of pTTSs. The both
tools provide a user with information about TTS
sequence length and gene region locations. However,
the information about TTS within intergenic and
intragenic regions of a given protein-coding gene, and
any freely selected region on a chromosome might be
also important for many reasons, but such opportunities
are not available through these two bioinformatics tools.
In the context of discovery and analysis of complex
genome regulatory elements and genome architectures, it
might also be important to study co-localization patterns
of natural TTSs, G4 motifs, precursors of non-coding
RNAs (ncRNAs), ncRNA targets and other regulatory
elements. However, that kind of analysis has not been
carried out yet.
In this work we identify and annotate highly-specific
pTTSs in any region of human genome and integrate this
information with G4 dataset and several USCS genome
browser [21] annotation tracks of reported genes, gene
models, mRNAs and ESTs. We also provide a multi-track
view of the sequences together with several key DNA
regulatory elements, including CpG islands, transcrip-
tion factor (TF) binding sites (BS), single nucleotide
polymorphisms (SNPs), nucleosome occupancy profile,
repeat sites, and ncRNA precursors and ncRNA gene
targets.
Results
TTS mapping tools features
T h es c h e m ao fd a t af l o wi nt h eTTS mapping tools is
presented on Figure 2 and described in the Methods
section. We have developed a web-based search tool to
find polypurine sequences, which could be pTTSs, and to
map them to human genome along with annotation
tracks from a number of other databases. The web
interface allows a user to modify various search para-
meters (see Figure 3). The search parameters (chromo-
some position, minimum and maximum length of TTS,
number of pyrimidine insertion, percentage of guanine
composition, and repeat masking) defined by user are
used as criteria for TTS searching. The default TTS search
parameters were set with minimum of TTS length of
15-nt, minimum percent G composition of 50%, and
number of pyrimidine insertion of 1. To display the TTS
density in a given region in UCSC genome browser, the
TTS density option (defining window span and moving
step) is provided. In addition, the form also allows a user
to choose several annotation tracks used for chromo-
some position characterization and for the annotation of
pTTSs-containing genomic regions.
TTS search parameters
TTS length correlates with TTS uniqueness in the human genome
The statistics of pTTSs aligned against the human
reference genome (hs18) is studied in this section. The
statistical distribution of TTS length demonstrates that
relatively short TTS sequences (15-19 nt length) often
map many genome regions (Additional File 1, 2).
However, a vast majority of TTSs with length larger
than 18 nt exhibits unique genome coordinates. Using
BLAST algorithm (see Method section), we found the
uniquely located pTTSs and counted their abundance.
We found 519,971 TTSs in the reference human genome.
Table 1 shows that pTTS sequences with length 19-24 nt
are most often occurred in the genome (58% (303,789/
519,971)) than the short (15-18 nt; 13%) and the long
(25-872 nt; 29%) TTSs, respectively.
We also count the number uniquely located pTTSs
identified by Wu et al. [22]. Table 1 shows that the total
number of TTSs in our DB contains 55% of TTSs reported
by Wu at al. However, this table also shows that short
T T S sc o n s i s to fam a j o rf r a c t i o n( 4 6 % )o ft h eT T S
population. The numbers of medium-length (19-24 nt)
and long-length uniquely located TTSs in the both
databases (DBs) are similar. Thus, our DB exhibits
stronger filtration of the short TTSs than Wu et al. DB.
This difference could be explained by difference in pTTS
alignment criteria and additional filtering procedures
related to multiple mapping of the pTTSs reported in
[22]. More information regarding a comparison of non-
unique and unique sequences in the DBs is presented in
Additional file 2.
Pyrimidine insertion
Another limitation of triplex binding is pyrimidine
insertion in TTS. Only a single pyrimidine insertion
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modified TFOs can overcome the limitation, the inser-
tions still affect triplex stability in these cases [24].
Nevertheless, a few pyrimidine insertions still have to be
considered. There are several reports in the literature
about the use of modified TFO for an efficient inhibition
of gene expression. For example, for the inhibition of
MYC gene expression it was demonstrated that a 25
nucleotides long TTS with 3 thymine based insertion was
required [25,26]. Therefore, our TTS mapping keeps a
flexibility of search for pTTSs with pyrimidine insertion.
G content and TTS length
I tw a ss h o w nt h a tT F O sa r ea b l et of o r ms t a b l et r i p l e x
structures when their length is at least seven nucleotides
(nt) [27]. The further studies indicated that TFOs longer
than 7 nt can form more specific bonds with their targets
than the shorter ones [15,28,2 9 ] .M o s to fh i g h - a f f i n i t y
binding between TFO and TTS requires high G content
(>54% of the total nucleotide sequence length) in the
TTS sequences [15,23]. However, the experiment of
Vekhoff et al. demonstrates that GU-TFOs can form
stable triplexes to its target with minimal G composition
of 40-50%, depending on TFOs or TTS length and
sequence context [30].
The latter three components were used to identify pTTSs,
depending on the user’sc h o i c e .I nTTS mapping tool, 15
n u c l e o t i d e si su s e da st h ed e f a u l tm i n i m a lT T Sl e n g t h ,
because, even though 15 nucleotides length does not
guarantee a strong uniqueness, such sequences may still
be interesting if they overlap with transcription factors
binding sites or other regulatory elements. The default
minimal G content is set to 50%. This value was chosen
in order to ensure that triplex structure could be formed
a n db es t a b l e[ 3 0 ] .
Figure 2
Schema of data flow in TTS mapping. A chromosome coordinate is used to initiat eas e a r c ho fp T T S si nag i v e nr e g i o na n d
map pTTSs to several annotation tracks. The pTTSs search parameters should be provided by user or by default. The results of
the search are reported in a summary table and also forward to map the given pTTS to selected annotation tracks. After
mapping all pTTSs to available annotation tracks, the number of found annotation tracks, the number of the annotation tracks
overlapped with these pTTSs, and number of the pTTSs overlapped with the annotation tracks are reported to summary table.
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The interface page of TTS mapping tools. To run the program, user has to define chromosome region and parameters for
TTS search. "TTS density" option could be used to show TTS density in the running window with a given span and window
moving step.
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The results page displays summary tables (Figure 4) in
several topics. The first one, the region information
table, describes the genome version in UCSC database
and NCBI database, chromosome bands, chromosome
position, and length. The second one, the table of the
pTTSs search parameters, describes the parameters
defined by user. The third one, the pTTSs statistics
table, describes the number of pTTSs found in the given
chromosome position and descriptive statistic for each
strand separately and both strands taken together. The
user can view the table of the descriptive information
and list of annotation tracks overlapped of each pTTS
(Figure 5) by clicking at “View” or display the pTTSs on
UCSC genome browser by clicking at “Browse” beside
the table. The fourth one, the gene table, describes the
gene name and transcript identifier (transcript ID),
appearing in a given chromosome region, the number
of pTTSs overlapping with the gene, and number of
pTTSs found in gene-associated locations (exon, intron,
5’UTR, 3’UTR, and 2 kb up/down stream of gene). More
details on each pTTS in a gene are provided in the link
for the total number of pTTSs (Figure 4). The detailed
information about pTTSs in a gene includes: nucleotide
sequence, chromosome position, percent G composi-
tion, type of sequences (polypurine or polypyrimidine),
the distances of pTTS from TSS and from start or end of
gene, and gene locations. The fifth one, the set of other
summary tables, contains the information about the
annotation tracks, which are G4, CpG Island, snoRNA,
miRNA, SNPs, TFBS, and miRNA targets. The summary
table of annotation tracks describes the number of tracks
found, the number of tracks containing pTTSs, and the
number of pTTSs located in the tracks. Links in these
tables are provided to display the detailed information
for each track.
List of found pTTSs and integrative annotation information
The descriptive information about pTTSs is listed in a
t a b l eb yT T SI D( i nF i g u r e5 ) .T T SI D sa r ec r e a t e d
consisting of 17 characters in the following order: “TTS”,
pyrimidine insertion, %G, chromosome, start position
of pTTS, for example: “TTS 3 50 08 128815591”.E a c h
TTS ID refers to sequence, chromosome position, G
composition percent, an overlapping tandem repeat, an
overlapping known repeat element overlapped, over-
lapping annotation tracks overlapped, and a BLAST
genome link, which is used to evaluate the uniqueness of
pTTSs in human genome. An application for sorting and
filtering tables is accessible in column captions. In
addition, the user can click on TTS ID to display its
descriptive information and details on each overlapping
annotation track overlapped.
Descriptive statistics table of pTTSs and the genomic regions
overlapping with pTTSs
Detailed descriptive information about each pTTS is
described in a table represented in Figure 6. Descriptive
information table contains pTTS sequence, chromosome
position, strand, %G, the number of pyrimidine inser-
tions, tandem repeats, and known overlapping repeat
regions. The table also displays overlaps of the pTTS with
genes. The detailed information about other overlapping
tracks is also displayed when such tracks overlapping are
found. A case study of pTTSs found in the genes of
transcription factors
It has been shown that TTS could be co-localized with
TFBSs in the same putative promoter region [15,23,30]. For
insurance, figure 7 shows several pTTSs found by our TTS
mapping software in the region of MYC gene. In zooming
region on Figure 7 the start position of MYC gene includes
the uniquely mapped TTS TTS15008128817597) which
overlapped with the TFBS V$E2F_02. The next downstream
TTS (TTS15008128817681) is located in the fist exon of
MYC gene which overlapped also with BS V$P300_01.
However, TTS15008128817681 pTTS has multiple loca-
tions in the human genome. Additionally, several other
annotation tracks including G4, TFBS, miRNA target, and
CpG Islands are also displayed on Figure 7. More detailed
information about pTTSs and other putative regulatory
sequences is presented in the supplementary materials
(additional files 3, 4). Using BLAST alignment of pTTS
TTS15008128817597 against the human genome we
found a unique location of the pTTS. This TTS is
overlapped with the TFBS V$E2F_02. Potential importance
of TTS TTS15008128817597 for anti-gene therapy has
been demonstrated. Inhibition of gene expression via pTTS
TTS15008128817597 in vitro was found by several
research groups [25,31,32].
Table 1: A comparison of the frequencies of uniquely mapped pTTSs found in the TTS databases
TTS length Number of unique pTTSs Ratio of [B] and [A]
Wu et al. 2007 [A] TTS mapping [B]
Short 15-18 441471 (46%) 67292 (13%) 0.152
Medium 19-24 371267 (39%) 303789 (58%) 0.818
Large 25-872 140882 (15%) 148890 (29%) 1.057
all length 15-872 953620 (100%) 519971 (100%) 0.545
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The summary tables of pTTSs search and mapping in a human genome region. The results display summary tables
of: chromosome position, TTS search parameters, statistics of pTTSs found, the gene appearing in the given chromosome
position, and the data of selected annotation tracks found in the chromosome region.
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TTS15003170347908 which sequence is unique in the
genome and is overlapped with the TFBS V$MZF1_02.
MZF1 is TF belonging to the Krüppel family of zinc finger
proteins,expressedintotipotenthemopoieticcellsaswell
as in myeloid progenitors. MZF1 can act as a tumor/
growth suppressor in the hemopoietic compartment [33].
T h es a m ep T T Si sa l s ol o c a t e di nEVI-1 gene isoforms: the
first exon of NM_001105078 and in putative 2 Kb-
promoter regions of EVI-1isoforms NM_001105077 and
NM_005241. Detailed information about EVI-1 region is
presented in supplementary materials (additional files 5,
6, 7, 8). We found no evidences in the literature of
possible function or therapeutic applications of this
pTTS. Biological importance and clinical significance of
these associations requires a further investigation. The
presented results suggest that simultaneous mapping of
specific regulatory elements (unique pTTS and TFBS)
presented on Figure 8 could provide important informa-
tion regarding new application in targeting EVI-1 genes.
TTS and G4 co-occurrence
It has been shown that polypurine oligonucleotides can
form antiparallel triplexes with G-rich TTSs in promoter
regions of c-myb, MYC, Ki-ras (and some other oncogenes)
and reduce both the proliferation and colony formation in
tumor cells [16,25,34]. These G-rich TTSs could be also
overlapped or included in the G4 DNA and/or G4 RNA
structures, which probably could modify gene expression
due to triplex formation at both the transcription and post-
transcription levels [34,35]. We observed many putative
promoter regions (around transcription start position)
where pTTS and G4 are overlapped or imbedded. The
examples of such co-localization events are presented on
Figure 7 and Figure 8. Figure 7 shows a map of pTTSs and
other regulatory elements on MYC gene region. Table 2
shows detailed information about G4 track overlapped TTS
in MYC promoter region generated by link to G4 track
presented in the Figure 4. Two G4 sequences (Quad-8-
CCC-5773 and Quad-8-CCC-5774) present in a vicinity of
start position of MYC gene. One of these G4s,
Quad-8-CCC-5773 is overlapped with pTTS
TTS15008128817345 and includes other pTTS
(TTS15008128817365) (Table 2). Note, G4 Quad-8-
CCC-5774 is located in 5’UTR region and does not show
overlapping with any TTS (Figure 7). In the case of EVI-1
gene two TTS (TTS15003170348263 and
TTS15003170348279) are overlapped with G4 (Quad-3-
GGG-8104) in the putative promoter region (Figure 8).
These examples suggest a new challenge for systematic
study of TTS and G4 interactions and an opportunity for
optimization triplex anti-gene therapy.
TTS can co-occurred in ncRNA precursor
Output of TTS mapping e x h i b i t sa no f t e no c c u r r e n c eo f
TTSs in the precursors of small ncRNAs located in the
introns of protein coding genes. For instance, figure 9A
Figure 5
The list of pTTSs and integrative annotation information. The list of to TTS ID which describe the descriptive
information of each pTTSs and integrate annotation tracks overlapped with pTTSs. The link of TTS ID enable the user to view
information about pTTSs in context of the chromosome sequence, tandem repeat inside the pTTSs, the known repeat element
overlapping with pTTSs, other annotation tracks overlapped, and the BLAST genome link. The BLAST link is use to view the
uniqueness of pTTSs on the human genome.
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Result Tables on the properties of pTTS and neighboring annotation information. Descriptive information about
pTTS, neighboring gene region which overlapped with the pTTS and annotation tracks which overlapped with the given pTTS.
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483, located in intron 2 of short isoform of IGF2 gene. The
IGF2 gene encodes a member of the insulin family of
polypeptide growth factors that is involved in development
and growth. IGF2 can stimulate various cellular responses
acting as a cell survival factor or mitogenic factor and can
also modify metabolism. It is an imprinted gene and is
expressed only from the paternally inherited allele.
Although IGF2 is normally only transcribed from the
paternal allele, maternal imprinting is lost in many tumors,
leading to biallelic expression of the gene. Disruption of
imprinting and the resulting increase in gene dosage have
been implicated in tumor transformation in a variety of
human tissues [36]. Loss of IGF2 imprinting leads to an
oncogenic diathesis that enhances the risk for neoplastic
transformation. There is a read-through, INS-IGF2,w h i c h
aligns to this gene at the 3’ region and to the upstream INS
gene at the 5’ region.
TTS mapping found two polypurine pTTSs and two
polypyrimidine pTTSs in intron 2 of IGF2 (Table 3).
These pTTS sequences are located in the evolutionally
conserve region of intron 2 of IGF2. Note that the
Triplex-forming Oligonucleotide Target Sequence Search
engine http://spi.mdanderson.org/tfo/about.php lost
TTS GTGGGGGAGAGGGGGAAGA in output overlapped
gene table. Figure 9B shows secondary structure of
miRNA precursor (hsa-mir-483) which includes poly-
purine and polypyrimidine sequences within a region of
the mature siRNA. Interestingly, intron 2 of IGF2
contains a large number (9 transcripts) of overlapping
transcripts, while in intron 1, intron 3, and intron 4 the
number of overlapping transcripts was 0, 2 and 1,
respectively. Figure 9B also shows the location of
transcript polypurine or polypyrimidine sequences in
intron 2 on the secondary structure of the siRNA derived
from intron 2. DNA sequence TTCCATCACG, the linker
between polypurine (GAGGGGGAAGACGGGA-
GGAAAGAAGGGAGTGG) and polypyrimidine
(CTCTCCTCTTCTGCCCTCCTCTCCTCACTCCTCC)
sequences of mir-483 precursor, forms a non-
complimentary head of the RNA harping loop
Figure 7
Mapping of pTTSs and other regulatory elements on MYC gene region. Bottom plot shows detail map of pTTSs and
maps other regulatory elements on MYC gene region and up plot shows zoomed region and regulatory sequences in the
vicinity of start position of MYC gene. Red oval in the zoomed region: The uniquely mapped TTS (TTS15008128817597)
l o c a t e di nt h ef i r s te x o no fMYC gene is overlapped with the TFBS V$E2F_02 and with the CpG island. The next downstream
TTS (TTS15008128817681) in the fist exon of MYC gene is also overlapped with other TFBS V$P300_01. However, for the
last pTTS multiple locations in the human genome were found. Two G4 sequences (Quad-8-CCC-5773 and Quad-8-CC-
5774) are also shown in a vicinity of start position of MYC gene One of this G4 (Quad-8-CCC-5773) is overlapped with pTTS
TTS15008128817345 and include other pTTS TTS15008128817365.
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(page number not for citation purposes)(UUCCAUCACG). This linker sequence is not evolutio-
narily conserved.
TTS mapping could predict the non-trivial functional
links between genome localization of specific
evolutionally conserved TTSs and essential regulatory
protein-coding genes, natural siRNA precursors and
share TF BS in gene promoter regions. For instance, the
TTS-rich regions included into intron 2 of IGF2 gene
covers the mir-483 precursor region. One of TTS includes
Figure 8
Mapping of pTTSs and other regulatory elements on EVI-1 gene region. Red oval: the unique pTTS is overlapped with
transcription factor binding site.
Table 2: G4 and pTTSs overlapping in the MYC promoter and MYC intragenic regions pTTSs overlapped with G4s are in bold type
G4 ID Sequence Chr Start End Strand TSS ID
Quad-8-CCC-5773 CCCCACCTTCCCCACC
CTCCCCACCCTCCCCATAAGCGCCCC
TCCCGGGTTCCC
Chr8 128817351 128817404 - TSS15008128817345
TSS15008128817365
Quad-8-CCC-5771 CCCCCTGCCCCTCCCATATTCTCCC Chr8 128816440 128816464 - TSS15008128816440
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(page number not for citation purposes)Figure 9
Mapping of pTTSs and miRNA included into IGF2 gene region. A: Mapping on primary miRNA (hsa-mir-483) and
pTFO on the evolutionally conserve intronic region of IGF2 gene. B: secondary structure of primary miRNA (hsa-mir-483).
Pink color of nucleotide symbol: mature siRNA, blue color of nucleotide symbol: polypurine sequence, red color of nucleotide
symbol: polypyrimidine sequence located on the some strand as double helix DNA. One substitution on Y in the R starch is
allowed. C: pTTS (TTS15011002112005) includes binding site (TTCCCCTCTCCC) of transcription factor MZF1.
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(page number not for citation purposes)binding site of TF MZF1. Figure 9C shows that one of
four pTTS (TTS15011002112005) includes the binding
site (TTCCCCTCTCCC) of TF MZF1. Additionally, TTS
mapping exhibits trimethylation of hystone 3 lysine in
the position 27 (H3K27met3) and an absent of
trimethylation of hystone 3 lysine in position 4
(H3K4met3) of IGF2 gene region observed in several
cancer cell types, which suggests that transcription of the
both IGF2 gene and mir-483 is suppressed. We suggest
that the TTSs could form triplexes in and TTS-rich regions
included into intron 2 of IGF2 gene and, thus, TTS-TFO
complex might be involve in mechanisms of local
epigenetic regulation of repressive heterochromatin
directly or/and through the recruitment of specific
proteins (for instance, MZF1 and triplex-binding pro-
teins directly interacting with TTSs). Data on negative
nucleosome occupancy of evolutionarily conserved TTSs
in the mir-483 precursor region (Figure 9), exhibited in
USCS viewer, support our hypothesis. Thus, we could
suggest that both the IGF2 gene and the precursor mir-
493 are essential genes (in fetal tissue development and
cancer growth) which might be controlled by genetic and
epigenetic mechanisms driven by natural TTSs-TFO
complexes.
Discussion
In this work we provided an automatic cartography of
specific pTTSs within the human genome and integrated
this information with other identified regulatory DNA
motifs and sites. Our analysis shows that TTS mapping
can provide a comprehensive and detailed analysis of
integrity TTSs with other genomic regulatory signals
essential for understanding of genome stability and gene
expression.
We developed a flexible web-based search tools for
finding, annotating TFO G-rich TTSs within the human
genome and integrating this data with G4 motifs and
other regulatory elements, including CpG Island, miRNA
precursors, miRNA targets, transcription factor binding
sites (TFBSs), Single Nucleotide Polymorphisms (SNPs),
small nucleolar RNAs (snoRNA), nucleosome potential
and repeat elements. Descriptive information about each
genome region, including sequence context overlapping
annotated DNA sequence regions and gene regions (e.g.
introns and exons) and putative promoter and down-
stream region is provided. The engine assists the user in
finding highly-specific TFO TTS (pure polypurine
sequences with length larger than 14 bp) and “moderate
specific” TFO TTS (TFO purine target sites with length
larger than 14 bp, including 1, 2 or 3 pyrimidine
insertions).
Using well studied oncogenes MYC and EVI-1,w h i c h
exhibit strong recombination- and mutation-prone
functions (which are often associated with human
malignancies) as examples, we demonstrated that pTTS,
TFBS, and miRNA targets and several other regulatory
elements could be synergistically involved in co-mod-
ulation of the promoter regions of MYC and EVI-1.
TTS mapping reveals that a high-complementary evolu-
tionarily conserved polypurine and polypyrimidine
motif pair linked by the non-conserved short sequence,
form miR-483 precursor. Originally, miRNA hsa-miR-
483 was located in chromosome 11 and was identified
by [37] in fetal liver in human. In addition, miR-483 was
annotated in mouse and rat by sequence similarity in
mirBase [38,39]. This ncRNA was detected in an
automatic scan (composite score 8.6, energy 31.4) and
w a ss c o r e dh i g h l ya sam i R N Ab yR N A m i c r o[ 4 0 ] .H s a -
miR-483 was also detected by RNAz but was not in the
input set for EvoFold [41]. Predictions of miR-483, in
addition to human, rat and mouse, also were made for
dog, cow, horse and rabbit http://people.csail.mit.edu/
akiezun/miRviewer/mir-483_index.html. So, miR-483
DNA precursor is strongly conserved across many
mammals and contains a high-complementary polypur-
ine and polypyrimidine motif pair linked by a short low-
conserved sequence forming hairpin loop of secondary
structure of this ncRNA. miRNA can be co-transcribed by
RNAPol-II with protein-coding gene IGF2 in which
miRNA precursor is embedded. We suggest that R-Y
TTS pair forming a natural DNA-RNA triplex within
precursor mir-483 transcribing from the second intron of
IGF2 gene might be an important target for endogenous
regulation of the functions of this ncRNA in the human
cells.
BLAST aligning of pTTS with the reference human
genome revealed the unique overlapping of pTTS with
Table 3: Four TTSs overlapped with mir-483 precursor
TTS ID Sequence TTS Length Chromosome Start End Strand %G sno/
miRNA ID
TTS15011002111984 GGGAGGAAAGAAGGGAGTGG 20 chr11 2111984 2112003 reverse 60 hsa-mir-483
TTS15011002111953 GGGAGGAGAGGAGTGAGGAGG 21 chr11 2111953 2111973 forward 67 hsa-mir-483
TTS15011002111932 AAGGGCAGGAGAGGAGAAGA 20 chr11 2111932 2111951 forward 50 hsa-mir-483
TTS15011002112005 GTGGGGGAGAGGGGGAAGA 19 chr11 2112005 2112023 reverse 68 hsa-mir-483
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(page number not for citation purposes)TFBSs (Figure 8 and Figure 9). Inhibition of gene
expression via TFOs forming the triplexes with such
TTSs was demonstrated by several research groups
[25,31,32]. In particular, it was shown that triplex-
forming oligonucleotides can bind with a high specificity
to the MYC promoter in HeLa cells, thereby reducing
MYC mRNA levels in the cells [25,31,32].
Figure 8 and Figure 9C shows that pTTSs
TTS15003170347908 and TTS15011002112005 include
common anti-sense sequence of BSs of TF MZF1 (having
TFBS TTCCCCTCTCCC) which could mediate a control
of transcription of genes IGF2 and EVI-1(Figure 8). These
examples suggest that transcription of two (or more)
essential genes could be specifically directed via a single
highly-homologous TTS. Other DNA-binding proteins
(e.g. nuclear protein bound the TTS in promoter region
of Ki-ras and MYC genes [14,34]) can induce site-specific
modifications of genome DNA structures and, finally,
changes of gene expression. Additionally, silencing
mechanism(s) of the gene expression could be regulated
by some proteins directly interacting with pyrimidine-
rich motif (s) of RNAs. For instance, CRD-BP/IMP1 is an
oncofetal RNA-binding protein which, via short pyrimi-
dine-reach binding sites, specifically recognizes several
RNAs, including the leader 3’ IGF2 mRNA and MYC
mRNAs [42-44]. de novo CRD-BP/IMP1 expression has
been detected in human tumors of different origins, and
in some of these tumors characterizes the vast majority
of the samples studied (see [42,43] for references).
However, the possibility of mir-483 to form triplex
structures (RNA-DNA-DNA or DNA-DNA-DNA) and the
possibility of CRD-BP/IMP1 protein to interact with
mRNA of IGF2 gene might play an important role in our
understanding of the specific control of IGF2 and mir-
483 precursor expression.
Conclusion
TTS mapping provides a comprehensive visual and
analytical tool to help a user to find pTTSs, G4s and
other regulatory DNA structures and genomic regions.
Our pipeline allows us (i) to discover diverse biologi-
cally meaningful complex genome elements, (ii) identify
novel biomarkers of complex diseases and their unique/
specific combinations.
TTS Mapping provides not only bioinformatics support,
due to its sequence visualization tools and statistical
tables, but also integrates knowledge about many diverse
DNA structures and their annotation tracks. Our results
suggest that recombination-prone and mutation-prone
genes EVI-1 and MYC is significantly enriched with co-
occurring regulatory DNA sequences including TTSs and
G4s, which could be used to develop novel approaches
for gene therapy based on highly-specific TFO-TTS
interactions.
TTS Mapping predicts the existence of a sub-set of natural
ncRNAs forming hairpin secondary structures, including
high-complementary and evolutionarily conserved poly-
purine- and polypyrimidine-rich stem and non-con-
served polypurine/polypyrimidine hairpin loops with
varying purine/pyrimidine content. Such R-Y paired
ncRNAs could form siRNA and miRNAs, which might
be involved in silencing and activation of expression of
many dozens of essential genes. The DNA precursors of
such Y-R paired ncRNAs might be also considered as
prospective targets for high-specific anti-gene therapy.
Methods
Data sources
The human genome sequences are prepared for TTSs
searching in two different data sets: the first data set is
human genome sequence hg18 (NCBI Build 36.1); the
second data set corresponds to the same genome
sequence (hg18), for which DNA repeat regions were
masked (RepeatMasker/RepBase update 9.11) [45]. The
genome data for BLAST was prepared Makeblastdb
software (NCBI Blast 2.2.19+ package) from human
genome sequence without repeat masking. NCBI BlastN
software [46] was used to verify the uniqueness of each
TTS. UCSC annotation tracks (refGene, cpgIslandExt,
snp129, targetscans, tfbsConsSites, and wgrna) were
integrated for mapping pTTSs with annotation tracks.
G-quadruplex sequences, predicted by Quadparser, were
provided at http://www.quadruplex.org. The search
engine of TTS mapping is available for a public access at
http://ggeda.bii.a-star.edu.sg/~piroonj/TTS_mapping/
TTS_mapping.php.
Construction and Implementation of TTSs mapping
The aim of TTSs mapping pipeline is to provide users with
a flexible pTTSs search tool for polypurine sequences in
the human genome and to integrate the pTTSs mapping
data with available annotation tracks which could be
associated with structural and functional properties of
the TTSs. Our web tool requests a chromosome position
as an initial search parameter. To form the triplex, the
given pTTS should match the following specifications
[15,23,30]: (a) minimal and maximal pTTS sequence
length, (b) minimal guanine (G) content percent, (c)
number of non-contiguous pyrimidine insertions, and
(d) human genome sequences with or without repeat
masking. Detailed information about optimal selection
of these parameters is presented in the next section. TTS
mapping provides optimal parameters of pTTS searching
by default and also it allows the users to choose the
parameters for mapping pTTSs optionally (see section
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localization of G-quadruplexs, miRNAs, snoRNAs,
miRNA gene targets, TFBSs, SNPs, nucleosome occu-
pancy profiles could be also observed and statistically
analysed. The data flow schema is showed in Figure 2.
The results of the search are reported in a summary table,
and are used as input data for integrate mapping of
pTTSs with available annotation information.
Figure 3 shows the interface page of TTS mapping tools.
Figure 4 shows how search results are combined in
summary tables containing: genome region-specific
information, pTTS searching parameters, statistics of
pTTSs found in the given region, references to gene
sequence databases (via refGene from UCSC). That
information is reported for the each gene found in the
given genome region overlapped with pTTS, and the
annotation tracks found in the given region and over-
lapped with pTTSs. In addition, the summary results
page provides links to view the pTTSs details and to
display all the available tracks in UCSC bioinformatics
browser. TTS mapping tool is implemented in Perl
language.
Criteria of identification of pTTS sequences
The TTS mapping tool is used to identify pTTSs in the
reference human genome (hg18). The initial parameters
for the program search were the following: minimal
lengthofTTS is≥15nt,minimalguaninecontentis≥50%,
the number of pyrimidine insertions could be ranged
from 0 nt to 3 nt (1 nt insertion is by default). Using these
criteria, the pTTS sequences were computationally
mapped on the human chromosomes. We used NCBI
BLAST program for alignment of these sequences against
human genome to count the copy number of the given
pTTS present in the genome. The unique pTTSs defined as
the sequences found only in a single position in the
genomewerealsoidentified.ThissetofuniquepTTSswas
divided into three groups: short-length TTSs (15-18 nt
long), medium-length TTSs (19-24 nt long), and large-
lengthTTSs(>25ntlong).ThenumberofpTTSintheeach
set was computed and compared with the number of
unique pTTSs previously described by Wu et al. [22].
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